Wednesday, July 8, 2026

Patent intelligence · US

US 9757336

Method for formulating large diameter synthetic membrane vesicles

granted A61KA61K31/445A61K31/4458A61K9/127
Status granted
Linked drugs 2
Pipeline programs 6
Years to expiry 11
Applicant portfolio 57
Patent details — US 9757336
Jurisdiction
US
Status
granted
Grant date
Sep 12, 2017
Expiration
Sep 7, 2037
Claims
15
CPC classes
A61K, A61K31/445, A61K31/4458, A61K9/127
View on Google Patents ↗

Quick answer

US 9757336 (Method for formulating large diameter synthetic membrane vesicles) is held by Pacira Pharmaceuticals, Inc.. Status: granted. Granted Sep 12, 2017. Expires Sep 7, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
15
CPC classes
A61K, A61K31/445, A61K31/4458, A61K9/127, A61K9/1271, A61K9/1277

More from Pacira Pharmaceuticals, Inc.

Related pharmaceutical patents in our USPTO index.

  1. US 12370142

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Expires Jul 24, 2045

    granted
  2. US 12364764

    Sustained release thermosetting gels comprising sodium channel blockers and the methods of making same

    Pacira Therapeutics, Inc. · Expires Jul 17, 2045

    granted
  3. US 12318483

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Expires May 29, 2045

    granted
  4. US 12296047

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Expires May 8, 2045

    granted
  5. US 12285435

    Multivesicular liposome formulations of dexamethasone

    Pacira Pharmaceuticals, Inc. · Expires Apr 24, 2045

    granted
  6. US 12285419

    Bupivacaine multivesicular liposome formulations and uses thereof

    Pacira Pharmaceuticals, Inc. · Expires Apr 24, 2045

    granted
  7. US 12280149

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Expires Apr 17, 2045

    granted
  8. US 12251472

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Expires Mar 13, 2045

    granted

Frequently asked questions

What is US patent 9757336?

US 9757336 (Method for formulating large diameter synthetic membrane vesicles) is held by Pacira Pharmaceuticals, Inc.. Status: granted. Granted Sep 12, 2017. Expires Sep 7, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 9757336?

Pacira Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 57 pharmaceutical patents for this assignee.

When does US 9757336 expire?

Our index shows an expiration date of Sep 7, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.